Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 33
Filtrar
1.
Nucleic Acids Res ; 49(20): 11834-11854, 2021 11 18.
Artículo en Inglés | MEDLINE | ID: mdl-34751402

RESUMEN

RECQ1 is the shortest among the five human RecQ helicases comprising of two RecA like domains, a zinc-binding domain and a RecQ C-terminal domain containing the winged-helix (WH). Mutations or deletions on the tip of a ß-hairpin located in the WH domain are known to abolish the unwinding activity. Interestingly, the same mutations on the ß-hairpin of annealing incompetent RECQ1 mutant (RECQ1T1) have been reported to restore its annealing activity. In an attempt to unravel the strand annealing mechanism, we have crystallized a fragment of RECQ1 encompassing D2-Zn-WH domains harbouring mutations on the ß-hairpin. From our crystal structure data and interface analysis, we have demonstrated that an α-helix located in zinc-binding domain potentially interacts with residues of WH domain, which plays a significant role in strand annealing activity. We have shown that deletion of the α-helix or mutation of specific residues on it restores strand annealing activity of annealing deficient constructs of RECQ1. Our results also demonstrate that mutations on the α-helix induce conformational changes and affects DNA stimulated ATP hydrolysis and unwinding activity of RECQ1. Our study, for the first time, provides insight into the conformational requirements of the WH domain for efficient strand annealing by human RECQ1.


Asunto(s)
ADN de Cadena Simple/química , RecQ Helicasas/química , Sitios de Unión , ADN de Cadena Simple/metabolismo , Humanos , Simulación de Dinámica Molecular , Mutación , Unión Proteica , Conformación Proteica en Hélice alfa , RecQ Helicasas/genética , RecQ Helicasas/metabolismo , Zinc/metabolismo
2.
Biol Chem ; 402(5): 617-636, 2021 04 27.
Artículo en Inglés | MEDLINE | ID: mdl-33567180

RESUMEN

RecQ helicases are a highly conserved class of DNA helicases that play crucial role in almost all DNA metabolic processes including replication, repair and recombination. They are able to unwind a wide variety of complex intermediate DNA structures that may result from cellular DNA transactions and hence assist in maintaining genome integrity. Interestingly, a huge number of recent reports suggest that many of the RecQ family helicases are directly or indirectly involved in regulating transcription and gene expression. On one hand, they can remove complex structures like R-loops, G-quadruplexes or RNA:DNA hybrids formed at the intersection of transcription and replication. On the other hand, emerging evidence suggests that they can also regulate transcription by directly interacting with RNA polymerase or recruiting other protein factors that may regulate transcription. This review summarizes the up to date knowledge on the involvement of three human RecQ family proteins BLM, WRN and RECQL5 in transcription regulation and management of transcription associated stress.


Asunto(s)
ADN/metabolismo , ARN/metabolismo , RecQ Helicasas/metabolismo , Helicasa del Síndrome de Werner/metabolismo , ADN/química , Humanos , ARN/química , RecQ Helicasas/química , Helicasa del Síndrome de Werner/química
3.
Nucleic Acids Res ; 41(2): 1058-70, 2013 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23209025

RESUMEN

Reverse gyrase is an ATP-dependent topoisomerase that is unique to hyperthermophilic archaea and eubacteria. The only reverse gyrase structure determined to date has revealed the arrangement of the N-terminal helicase domain and the C-terminal topoisomerase domain that intimately cooperate to generate the unique function of positive DNA supercoiling. Although the structure has elicited hypotheses as to how supercoiling may be achieved, it lacks structural elements important for supercoiling and the molecular mechanism of positive supercoiling is still not clear. We present five structures of authentic Thermotoga maritima reverse gyrase that reveal a first view of two interacting zinc fingers that are crucial for positive DNA supercoiling. The so-called latch domain, which connects the helicase and the topoisomerase domains is required for their functional cooperation and presents a novel fold. Structural comparison defines mobile regions in parts of the helicase domain, including a helical insert and the latch that are likely important for DNA binding during catalysis. We show that the latch, the helical insert and the zinc fingers contribute to the binding of DNA to reverse gyrase and are uniquely placed within the reverse gyrase structure to bind and guide DNA during strand passage. A possible mechanism for positive supercoiling by reverse gyrases is presented.


Asunto(s)
Proteínas Bacterianas/química , ADN-Topoisomerasas de Tipo I/química , ADN Superhelicoidal/metabolismo , Thermotoga maritima/enzimología , Proteínas Bacterianas/metabolismo , Sitios de Unión , Cristalografía por Rayos X , ADN Helicasas/química , ADN-Topoisomerasas de Tipo I/metabolismo , ADN Superhelicoidal/química , Modelos Moleculares , Estructura Terciaria de Proteína , Dedos de Zinc
4.
Biol Chem ; 395(1): 83-93, 2014 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-23959663

RESUMEN

Reverse gyrase catalyzes the ATP-dependent introduction of positive supercoils into DNA. Supercoiling requires the functional cooperation of its N-terminal helicase domain with the C-terminal topoisomerase domain. The helicase domain contains a superfamily 2 helicase core formed by two RecA domains, H1 and H2. We show here that a helicase domain lacking the latch, an insertion in H2, fails to close the cleft in the helicase core in response to nucleotide and DNA binding at the beginning of the catalytic cycle. In the presence of the pre-hydrolysis ATP analog ADP·BeFx, however, the closed conformer can still be formed in the absence of the latch. The helicase domain lacking the latch exhibits reduced DNA affinities. The energetic difference between the two nucleotide states involved in duplex separation is diminished, rationalizing the unwinding deficiency of reverse gyrase lacking the latch. The latch most strongly contributes to binding of single-stranded DNA in the post-hydrolysis state, before phosphate release. Our results are in line with contributions of the latch in determining the direction of strand passage, and in orienting the cleaved single-stranded DNA for re-ligation. At the same time, the latch may coordinate the re-ligation reaction with strand passage and with the nucleotide cycle.


Asunto(s)
Adenosina Trifosfato/metabolismo , ADN Helicasas/metabolismo , ADN-Topoisomerasas de Tipo I/metabolismo , ADN de Cadena Simple/metabolismo , Thermotoga maritima/metabolismo , Adenosina Trifosfato/química , Adenosina Trifosfato/genética , ADN Helicasas/química , ADN Helicasas/genética , ADN-Topoisomerasas de Tipo I/química , ADN-Topoisomerasas de Tipo I/genética , ADN de Cadena Simple/genética , ADN Superhelicoidal/genética , ADN Superhelicoidal/metabolismo , Hidrólisis , Modelos Moleculares , Thermotoga maritima/enzimología , Thermotoga maritima/genética
5.
Nucleic Acids Res ; 39(5): 1789-800, 2011 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-21051354

RESUMEN

Reverse gyrase is the only topoisomerase that can introduce positive supercoils into DNA in an ATP-dependent process. It has a modular structure and harnesses a helicase-like domain to support a topoisomerase activity, thereby creating the unique function of positive DNA supercoiling. The isolated topoisomerase domain can relax negatively supercoiled DNA, an activity that is suppressed in reverse gyrase. The isolated helicase-like domain is a nucleotide-dependent switch that is attenuated by the topoisomerase domain. Inter-domain communication thus appears central for the functional cooperation of the two domains. The latch, an insertion into the helicase-like domain, has been suggested as an important element in coordinating their activities. Here, we have dissected the influence of the latch on nucleotide and DNA binding to the helicase-like domain, and on DNA supercoiling by reverse gyrase. We find that the latch is required for positive DNA supercoiling. It is crucial for the cooperativity of DNA and nucleotide binding to the helicase-like domain. The latch contributes to DNA binding, and affects the preference of reverse gyrase for ssDNA. Thus, the latch coordinates the individual domain activities by modulating the helicase-like domain, and by communicating changes in the nucleotide state to the topoisomerase domain.


Asunto(s)
Proteínas Bacterianas/química , ADN-Topoisomerasas de Tipo I/química , ADN/metabolismo , Thermotoga maritima/enzimología , Proteínas Bacterianas/genética , Proteínas Bacterianas/metabolismo , ADN Helicasas/química , ADN-Topoisomerasas de Tipo I/genética , ADN-Topoisomerasas de Tipo I/metabolismo , ADN de Cadena Simple/metabolismo , ADN Superhelicoidal/metabolismo , Nucleótidos/metabolismo , Unión Proteica , Estructura Terciaria de Proteína , Eliminación de Secuencia
6.
Nucleic Acids Res ; 39(8): 3295-309, 2011 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-21186185

RESUMEN

Most type IB topoisomerases do not require ATP and Mg(2+) for activity. However, as shown previously for vaccinia topoisomerase I, we demonstrate that ATP stimulates the relaxation activity of the unusual heterodimeric type IB topoisomerase from Leishmania donovani (LdTOP1L/S) in the absence of Mg(2+). The stimulation is independent of ATP hydrolysis but requires salt as a co-activator. ATP binds to LdTOP1L/S and increases its rate of strand rotation. Docking studies indicate that the amino acid residues His93, Tyr95, Arg188 and Arg190 of the large subunit may be involved in ATP binding. Site directed mutagenesis of these four residues individually to alanine and subsequent relaxation assays reveal that the R190A mutant topoisomerase is unable to exhibit ATP-mediated stimulation in the absence of Mg(2+). However, the ATP-independent relaxation activities of all the four mutant enzymes remain unaffected. Additionally, we provide evidence that ATP binds LdTOP1L/S and modulates the activity of the otherwise ATP-independent enzyme. This study establishes ATP as an activator of LdTOP1L/S in the absence of Mg(2+).


Asunto(s)
ADN-Topoisomerasas de Tipo I/química , ADN-Topoisomerasas de Tipo I/metabolismo , Leishmania donovani/enzimología , Adenosina Trifosfato/análogos & derivados , Adenosina Trifosfato/química , Adenosina Trifosfato/metabolismo , Cationes Bivalentes/química , ADN-Topoisomerasas de Tipo I/genética , ADN Superhelicoidal/metabolismo , Cinética , Magnesio/química , Modelos Moleculares , Mutación , Cloruro de Potasio/química
7.
ACS Macro Lett ; 11(2): 186-192, 2022 02 15.
Artículo en Inglés | MEDLINE | ID: mdl-35574767

RESUMEN

The laser light scattering experiments were performed to explore the role of dextran (size (d): 2.6, 6.9, and 17.0 nm) in compacting the plasmids (pBS: 2.9 kbps; pCMV-Tag2B: 4.3 kbps; and pET28a: 5.3 kbps) in vitro in the volume fraction (ϕ) range 0.01 to 0.15 of the macromolecular crowder. Two compaction regimes were observed in terms of the radius of gyration (Rg) for plasmid-dextran combinations, wherein the plasmid diffusivity is governed by normal diffusion and subdiffusion, respectively. Generalized scaling, Rg ∼ ϕ-1/(1+x), where x represents the conformational geometry of plasmids, is reported. The plasmid conformation depends on the crowder's size, with larger conformational changes observed in the presence of smaller crowders. The second virial coefficient (A2) and translational diffusion coefficient (Dt) indicate that entropically driven depletion of crowders, excluded volume, and interplasmid repulsive interactions govern plasmids' conformational changes, validated herein from the scaling of Dt with molecular weight.


Asunto(s)
ADN , Dextranos , Difusión , Conformación Molecular , Plásmidos/genética
8.
FEBS J ; 289(2): 394-416, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34355508

RESUMEN

RecQ helicases are superfamily 2 (SF2) DNA helicases that unwind a wide spectrum of complex DNA structures in a 3' to 5' direction and are involved in maintaining genome stability. RecQ helicases from protozoan parasites have gained significant interest in recent times because of their involvement in cellular DNA repair pathways, making them important targets for drug development. In this study, we report biophysical and biochemical characterization of the catalytic core of a RecQ helicase from hemoflagellate protozoan parasite Leishmania donovani. Among the two putative RecQ helicases identified in L. donovani, we cloned, overexpressed and purified the catalytic core of LdRECQb. The catalytic core was found to be very efficient in unwinding a wide variety of DNA substrates like forked duplex, 3' tailed duplex and Holliday junction DNA. Interestingly, the helicase core also unwound blunt duplex with slightly less efficiency. The enzyme exhibited high level of DNA-stimulated ATPase activity with preferential stimulation by forked duplex, Holliday junction and 3' tailed duplex. Walker A motif lysine mutation severely affected the ATPase activity and significantly affected unwinding activity. Like many other RecQ helicases, L. donovani RECQb also possesses strand annealing activity. Unwinding of longer DNA substrates by LdRECQb catalytic core was found to be stimulated in the presence of replication protein A (LdRPA-1) from L. donovani. Detailed biochemical characterization and comparison of kinetic parameters indicate that L. donovani RECQb shares considerable functional similarity with human Bloom syndrome helicase.


Asunto(s)
Leishmania donovani/genética , Leishmaniasis Visceral/genética , RecQ Helicasas/genética , Proteína de Replicación A/genética , Catálisis , Dominio Catalítico/genética , ADN/genética , Replicación del ADN/genética , ADN Cruciforme/genética , ADN de Cadena Simple/genética , Humanos , Leishmania donovani/patogenicidad , Leishmaniasis Visceral/parasitología , Especificidad por Sustrato/genética
9.
Anticancer Agents Med Chem ; 20(11): 1311-1326, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32418530

RESUMEN

Replication fork reversal and restart has gained immense interest as a central response mechanism to replication stress following DNA damage. Although the exact mechanism of fork reversal has not been elucidated precisely, the involvement of diverse pathways and different factors has been demonstrated, which are central to this phenomenon. RecQ helicases known for their vital role in DNA repair and maintaining genome stability has recently been implicated in the restart of regressed replication forks. Through interaction with vital proteins like Poly (ADP) ribose polymerase 1 (PARP1), these helicases participate in the replication fork reversal and restart phenomenon. Most therapeutic agents used for cancer chemotherapy act by causing DNA damage in replicating cells and subsequent cell death. These DNA damages can be repaired by mechanisms involving fork reversal as the key phenomenon eventually reducing the efficacy of the therapeutic agent. Hence the factors contributing to this repair process can be good selective targets for developing more efficient chemotherapeutic agents. In this review, we have discussed in detail the role of various proteins in replication fork reversal and restart with special emphasis on RecQ helicases. Involvement of other proteins like PARP1, recombinase rad51, SWI/SNF complex has also been discussed. Since RecQ helicases play a central role in the DNA damage response following chemotherapeutic treatment, we propose that targeting these helicases can emerge as an alternative to available intervention strategies. We have also summarized the current research status of available RecQ inhibitors and siRNA based therapeutic approaches that targets RecQ helicases. In summary, our review gives an overview of the DNA damage responses involving replication fork reversal and provides new directions for the development of more efficient and sustainable chemotherapeutic approaches.


Asunto(s)
Antineoplásicos/farmacología , Inhibidores Enzimáticos/farmacología , Neoplasias/tratamiento farmacológico , RecQ Helicasas/antagonistas & inhibidores , Antineoplásicos/química , Reparación del ADN , Replicación del ADN , Inhibidores Enzimáticos/química , Humanos , Neoplasias/metabolismo , RecQ Helicasas/metabolismo
10.
Antimicrob Agents Chemother ; 53(6): 2589-98, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19332675

RESUMEN

3,3'-Diindolylmethane (DIM), a novel poison targeting Leishmania donovani topoisomerase I (LdTOP1LS), induces programmed cell death in Leishmania parasites. The development of resistant parasites by adaptation with increasing concentrations of DIM generates random mutations in LdTOP1LS. Single-nucleotide mutations result in the amino acid substitutions F270L and K430N in the large subunit and N184S in the small subunit of the enzyme. DIM failed to inhibit the catalytic activity of the recombinant mutant enzyme (LdTOP1DRLS). Transfection studies of the mutant genes showed that the mutated topoisomerase I confers DIM resistance on wild-type Leishmania parasites. Site-directed mutagenesis studies revealed that a substantial level of resistance is conferred by the F270L mutation alone; however, all three mutations (F270L, K430N, and N184S) together are required to reach a higher-resistance phenotype. DIM fails to stabilize the topoisomerase I-DNA covalent complexes in the F270 mutant. Moreover, DIM cannot interfere with the religation step in the catalytic cycle of the recombinant F270L mutant enzyme. Taken together, these findings identify novel mutations in topoisomerase I that hinder its interaction with DNA, thereby modulating enzyme catalysis and conferring resistance to DIM. These studies advance our understanding of the mechanism of cell poisoning by DIM and suggest a specific modification of the drug that may improve its efficacy.


Asunto(s)
ADN-Topoisomerasas de Tipo I/genética , Inhibidores Enzimáticos/farmacología , Indoles/farmacología , Leishmania donovani/efectos de los fármacos , Mutación , Transportadoras de Casetes de Unión a ATP/fisiología , Animales , ADN-Topoisomerasas de Tipo I/química , Resistencia a Medicamentos , Indoles/farmacocinética , Leishmania donovani/genética , Inhibidores de Topoisomerasa I
11.
Mol Biochem Parasitol ; 165(1): 57-66, 2009 May.
Artículo en Inglés | MEDLINE | ID: mdl-19393162

RESUMEN

From the vanadate complex crystal structure of Leishmania donovani topoisomerase I, several amino acid residues have been implicated to be involved in the catalytic reaction. Although several predictions and propositions have been made, the exact role of these amino acids has not yet been clearly demonstrated in vitro. Among these residues, lysine 352 and arginine 314 stand as potential candidates for playing the role of a general acid during the cleavage step. In this study, we have characterized the role of lysine 352 on the large subunit, by site-directed mutagenesis and have tried to identify the general acid that can protonate the 5?-O atom of the leaving strand. Studies with the mutant enzymes reveal that, relaxation activity was severely affected when Lys352 was mutated to arginine or alanine (K352R or K352A). Mutation of Arg314 to Lys (R314K) has very little effect on the relaxation activity. Detailed study reveals that, both cleavage and religation steps are severely affected in case of K352R and K352A and the cleavage religation equilibrium is shifted towards the cleavage. On the contrary, the R314K mutant exhibits only a slightly slower rate of cleavage compared to wild-type enzyme. Cleavage assays with an oligonucleotide containing 5?-bridging phosphorothiolate indicate that Lys352 acts as a general acid in the cleavage step. Altogether, this study establishes the indispensable role of lysine 352 in the catalytic reaction of L. donovani topoisomerase I.


Asunto(s)
ADN-Topoisomerasas de Tipo I/genética , ADN-Topoisomerasas de Tipo I/metabolismo , Leishmania donovani/enzimología , Leishmania donovani/genética , Lisina/metabolismo , Mutación/genética , Animales , Catálisis , ADN/metabolismo , Cinética , Ligadura , Lisina/genética , Mutagénesis Sitio-Dirigida
12.
Biochem J ; 2008 Sep 29.
Artículo en Inglés | MEDLINE | ID: mdl-18823279

RESUMEN

This paper published as an Immediate Publication on 29 September 2008 was withdrawn by the Editorial Board of the Biochemical Journal on 12 December 2008.

13.
Biochem J ; 409(2): 481-9, 2008 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-17924857

RESUMEN

The unusual, heterodimeric topoisomerase IB of Leishmania shows functional activity upon reconstitution of the DNA-binding large subunit (LdTOPIL; or L) and the catalytic small subunit (LdTOPIS; or S). In the present study, we generated N- and C-terminal-truncated deletion constructs of either subunit and identified proteins LdTOPIL(39-456) (lacking amino acids 1-39 and 457-635) and LdTOPIS(210-262) (lacking amino acids 1-210) as the minimal interacting fragments. The interacting region of LdTOPIL lies between residues 40-99 and 435-456, while for LdTOPIS it lies between residues 210-215 and 245-262. The heterodimerization between the two fragments is weak and therefore co-purified fragments showed reduced DNA binding, cleavage and relaxation properties compared with the wild-type enzyme. The minimal fragments could complement their respective wild-type subunits inside parasites when the respective subunits were down-regulated by transfection with conditional antisense constructs. Site-directed mutagenesis studies identify Lys455 of LdTOPIL and Asp261 of LdTOPIS as two residues involved in subunit interaction. Taken together, the present study provides crucial insights into the mechanistic details for understanding the unusual structure and inter-subunit co-operativity of this heterodimeric enzyme.


Asunto(s)
ADN-Topoisomerasas de Tipo I/química , Leishmania/enzimología , Subunidades de Proteína/química , Proteínas Protozoarias/química , Animales , Ácido Aspártico/metabolismo , Secuencia de Bases , Dominio Catalítico , ADN/metabolismo , ADN-Topoisomerasas de Tipo I/metabolismo , Dimerización , Lisina/metabolismo , Modelos Genéticos , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , Subunidades de Proteína/metabolismo , Proteínas Protozoarias/metabolismo , Proteínas Recombinantes/química , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo
14.
Biochem J ; 409(2): 611-22, 2008 Jan 15.
Artículo en Inglés | MEDLINE | ID: mdl-17922678

RESUMEN

DIM (3,3'-di-indolylmethane), an abundant dietary component of cruciferous vegetables, exhibits a wide spectrum of pharmacological properties. In the present study, we show that DIM is a potent inhibitor of Leishmania donovani topoisomerase I with an IC50 of 1.2 microM. Equilibrium dialysis shows that DIM binds strongly to the free enzyme with a binding constant of 9.73x10(-9) M. The binding affinity of DIM to the small subunit is 8.6-fold more than that of the large subunit of unusual LdTOP1LS (bi-subunit L. donovani topoisomerase I). DIM stabilizes topoisomerase I-DNA cleavage complexes in vitro and also in vivo. Like CPT (camptothecin), DIM inhibits the religation step when the drug was added to preformed topoisomerase I-DNA binary complex. Hence, DIM is similar to CPT with respect to its ability to form the topoisomerase I-mediated 'cleavable complexes' in vitro and in vivo. But unlike CPT, DIM interacts with both free enzyme and substrate DNA. Therefore DIM is a non-competitive class I inhibitor of topoisomerase I. DIM also inhibits the relaxation activity of the CPT-resistant mutant enzyme LdTOP1Delta39LS (N-terminal deletion of amino acids 1-39 of LdTOP1LS). The IC50 values of DIM in simultaneous and enzyme pre-incubation relaxation assays were 3.6 and 2.9 muM respectively, which are higher than that of wild-type topoisomerase I (LdTOP1LS), indicating that the affinity of DIM to LdTOP1Delta39LS is less than that for LdTOP1LS. This is the first report on DIM as an L. donovani topoisomerase I poison. Our study illuminates a new mode of action of enzyme inhibition by DIM that might be exploited for rational drug design in human leishmaniasis.


Asunto(s)
Inhibidores Enzimáticos/toxicidad , Indoles/toxicidad , Leishmania donovani/enzimología , Proteínas Protozoarias/antagonistas & inhibidores , Inhibidores de Topoisomerasa I , Animales , Sitios de Unión , Camptotecina/farmacología , Catálisis , ADN/química , ADN/metabolismo , ADN-Topoisomerasas de Tipo I/química , ADN-Topoisomerasas de Tipo I/metabolismo , Relación Dosis-Respuesta a Droga , Humanos , Leishmania donovani/efectos de los fármacos , Subunidades de Proteína/antagonistas & inhibidores , Subunidades de Proteína/química , Subunidades de Proteína/metabolismo , Proteínas Protozoarias/química , Proteínas Protozoarias/metabolismo
15.
Int J Biol Macromol ; 123: 20-25, 2019 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-30389522

RESUMEN

In a type-II diabetes disease, amylin protein takes an incorrect structure that leads to the formation of the amyloid fibril. The conversion mechanism of amyloid fibril is not well understood. We have observed a repulsive interaction, in terms of second virial co-efficient (A2), between protein molecules in their native state in the PBS buffer through laser light scattering technique. The A2 switches from repulsive (positive A2) to attractive (negative A2) interactions with elapsed time favoring the formation and growth of the fibril. We report aggregation and fibril growth kinetics of amylin protein in different environmental conditions. The measurement of shape factor (ρ) through light scattering experiment shows a transition from coil-like structure to rod-like growth. In addition to rod-like growth, sheet-like growth of fibril is also observed through analytical and high-resolution TEM imaging techniques. The nucleation leading to elongation of fibrils as well as stacking of individual fibril perpendicular to the fibril axis is held by hydrogen bonding observed through high-resolution TEM.


Asunto(s)
Amiloide/metabolismo , Proteínas Amiloidogénicas/metabolismo , Polipéptido Amiloide de los Islotes Pancreáticos/metabolismo , Humanos , Enlace de Hidrógeno , Cinética
16.
Mol Pharmacol ; 74(5): 1292-307, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18703668

RESUMEN

Mitochondria are the principal site for the generation of cellular ATP by oxidative phosphorylation. F0F1-ATP synthase, a complex V of the electron transport chain, is an important constituent of mitochondria-dependent signaling pathways involved in apoptosis. In the present study, we have shown for the first time that 3,3'-diindolylmethane (DIM), a DNA topoisomerase I poison, inhibits mitochondrial F0F1-ATP synthase of Leishmania donovani and induces programmed cell death (PCD), which is a novel insight into the mechanism in protozoan parasites. DIM-induced inhibition of F0F1-ATP synthase activity causes depletion of mitochondrial ATP levels and significant stimulation of mitochondrial reactive oxygen species (ROS) production, followed by depolarization of mitochondrial membrane potential (DeltaPsi(m)). Because DeltaPsi(m) is the driving force for mitochondrial ATP synthesis, loss of DeltaPsi(m) results in depletion of cellular ATP level. The loss of DeltaPsi(m) causes the cellular ROS generation and in turn leads to the oxidative DNA lesions followed by DNA fragmentation. In contrast, loss of DeltaPsi(m) leads to release of cytochrome c into the cytosol and subsequently activates the caspase-like proteases, which lead to oligonucleosomal DNA cleavage. We have also shown that mitochondrial DNA-depleted cells are insensitive to DIM to induce PCD. Therefore, mitochondria are necessary for cytotoxicity of DIM in kinetoplastid parasites. Taken together, our study indicates for the first time that DIM-induced mitochondrial dysfunction by inhibition of F0F1-ATP synthase activity leads to PCD in Leishmania spp. parasites, which could be exploited to develop newer potential therapeutic targets.


Asunto(s)
Anticarcinógenos/farmacología , Apoptosis/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Indoles/farmacología , Leishmania donovani/efectos de los fármacos , Mitocondrias/efectos de los fármacos , ATPasas de Translocación de Protón/antagonistas & inhibidores , Especies Reactivas de Oxígeno/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Replicación del ADN , Activación Enzimática , Glutatión/metabolismo , Leishmania donovani/enzimología , Peroxidación de Lípido/efectos de los fármacos , Potenciales de la Membrana/efectos de los fármacos , Mitocondrias/enzimología , Mitocondrias/metabolismo , Estrés Oxidativo/efectos de los fármacos
17.
Mol Biochem Parasitol ; 158(2): 176-88, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-18243364

RESUMEN

ATP-binding cassette (ABC) transporters constitute the biggest family of membrane proteins involved in drug resistance and other biological activities. Resistance of leishmanial parasites to therapeutic drugs continues to escalate in developing countries and in many instances it is due to overexpressed ABC efflux pumps. Progressively adapted camptothecin (CPT)-resistant parasites show overexpression of a novel ABC transporter, which was classified as ABCG6. Transfection and overexpression of LdABCG6 in wild type parasites, shows its localization primarily in the plasma membrane and flagellar pocket region. Overexpressed LdABCG6 confers substantial CPT resistance to the parasites by rapid drug efflux. Various inhibitors have been tested for their ability to revert the CPT-resistant phenotype to specifically understand the inhibition of LdABCG6 transporter. Transport experiments using everted membrane vesicles were carried out to gain an insight into the kinetics of drug transport. This study provides further knowledge of specific membrane traffic ATPase and its involvement in the chemoresistance of Leishmania.


Asunto(s)
Transportadoras de Casetes de Unión a ATP/metabolismo , Antiprotozoarios/farmacología , Camptotecina/farmacología , Resistencia a Medicamentos , Leishmania donovani/efectos de los fármacos , Animales , Transporte Biológico Activo , Vesículas Citoplasmáticas/metabolismo , Humanos , Leishmania donovani/crecimiento & desarrollo , Pruebas de Sensibilidad Parasitaria , Proteínas Protozoarias/metabolismo
18.
Nucleic Acids Res ; 34(21): 6286-97, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-17098934

RESUMEN

The active site tyrosine residue of all monomeric type IB topoisomerases resides in the C-terminal domain of the enzyme. Leishmania donovani, possesses unusual heterodimeric type IB topoisomerase. The small subunit harbors the catalytic tyrosine within the SKXXY motif. To explore the functional relationship between the two subunits, we have replaced the small subunit of L.donovani topoisomerase I with a C-terminal fragment of human topoisomerase I (HTOP14). The purified LdTOP1L (large subunit of L.donovani topoisomerase I) and HTOP14 were able to reconstitute topoisomerase I activity when mixed in vitro. This unusual enzyme, 'LeishMan' topoisomerase I (Leish for Leishmania and Man for human) exhibits less efficiency in DNA binding and strand passage compared with LdTOP1L/S. Fusion of LdTOP1L with HTOP14 yielded a more efficient enzyme with greater affinity for DNA and faster strand passage ability. Both the chimeric enzymes are less sensitive to camptothecin than LdTOP1L/S. Restoration of topoisomerase I activity by LdTOP1L and HTOP14 suggests that the small subunit of L.donovani topoisomerase I is primarily required for supplying the catalytic tyrosine. Moreover, changes in the enzyme properties due to substitution of LdTOP1S with HTOP14 indicate that the small subunit contributes to subunit interaction and catalytic efficiency of the enzyme.


Asunto(s)
ADN-Topoisomerasas de Tipo I/metabolismo , Leishmania donovani/enzimología , Proteínas Protozoarias/metabolismo , Animales , Camptotecina/farmacología , ADN/metabolismo , ADN-Topoisomerasas de Tipo I/química , ADN-Topoisomerasas de Tipo I/genética , Polarización de Fluorescencia , Potasio/farmacología , Subunidades de Proteína/genética , Subunidades de Proteína/fisiología , Proteínas Protozoarias/química , Proteínas Protozoarias/genética , Proteínas Recombinantes de Fusión/metabolismo
19.
Nucleic Acids Res ; 34(4): 1121-32, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16488884

RESUMEN

Emergence of the bi-subunit topoisomerase I in the kinetoplastid family (Trypanosoma and Leishmania) has brought a new twist in topoisomerase research related to evolution, functional conservation and preferential sensitivities to the specific inhibitors of type IB topoisomerase family. In the present study, we describe that naturally occurring flavones baicalein, luteolin and quercetin are potent inhibitors of the recombinant Leishmania donovani topoisomerase I. These compounds bind to the free enzyme and also intercalate into the DNA at a very high concentration (300 microM) without binding to the minor grove. Here, we show that inhibition of topoisomerase I by these flavones is due to stabilization of topoisomerase I-DNA cleavage complexes, which subsequently inhibit the religation step. Their ability to stabilize the covalent topoisomerase I-DNA complex in vitro and in living cells is similar to that of the known topoisomerase I inhibitor camptothecin (CPT). However, in contrast to CPT, baicalein and luteolin failed to inhibit the religation step when the drugs were added to pre-formed enzyme substrate binary complex. This differential mechanism to induce the stabilization of cleavable complex with topoisomerase I and DNA by these selected flavones and CPT led us to investigate the effect of baicalein and luteolin on CPT-resistant mutant enzyme LdTOP1Delta39LS lacking 1-39 amino acids of the large subunit [B. B. Das, N. Sen, S. B. Dasgupta, A. Ganguly and H. K. Majumder (2005) J. Biol. Chem. 280, 16335-16344]. Baicalein and luteolin stabilize duplex oligonucleotide cleavage with LdTOP1Delta39LS. This observation was further supported by the stabilization of in vivo cleavable complex by baicalein and luteolin with highly CPT-resistant L.donovani strain. Taken together, our data suggest that the interacting amino acid residues of topoisomerase I may be partially overlapping or different for flavones and CPT. This study illuminates new properties of the flavones and provide additional insights into the ligand binding properties of L.donovani topoisomerase I.


Asunto(s)
Camptotecina/farmacología , ADN-Topoisomerasas de Tipo I/efectos de los fármacos , ADN/metabolismo , Inhibidores Enzimáticos/farmacología , Flavonoides/farmacología , Leishmania donovani/enzimología , Animales , ADN/química , ADN-Topoisomerasas de Tipo I/genética , ADN-Topoisomerasas de Tipo I/metabolismo , Flavanonas/química , Flavanonas/farmacología , Flavonoides/química , Luteolina/química , Luteolina/farmacología , Mutación , Subunidades de Proteína/metabolismo , Proteínas Protozoarias/efectos de los fármacos , Proteínas Protozoarias/genética , Proteínas Protozoarias/metabolismo , Quercetina/química , Quercetina/farmacología
20.
Adv Exp Med Biol ; 625: 103-15, 2008.
Artículo en Inglés | MEDLINE | ID: mdl-18365662

RESUMEN

Protozoan parasites of the genus Leishmania cause severe diseases that threaten human beings, both for the high mortality rates involved and the economic loss resulting from morbidity, primarily in the tropical and subtropical areas. This ancient eukaryote shows variable genetic diversity in their life cycle, wherein DNA topoisomerases play a key role in cellular processes affecting the topology and organization ofintracellular DNA. Kinetoplastid topoisomerases offer most attractive targets for their structural diversity from other eukaryotic counterparts and their indispensable function in cell biology Therefore, understanding the biology of kinetoplastid topoisomerases and the components and steps involved in this intricate process provide opportunities for target based drug designing against protozoan parasitic diseases.


Asunto(s)
Inhibidores Enzimáticos/farmacología , Leishmania/efectos de los fármacos , Leishmania/enzimología , Leishmaniasis/tratamiento farmacológico , Inhibidores de Topoisomerasa , Tripanocidas/farmacología , Animales , ADN-Topoisomerasas/clasificación , Sistemas de Liberación de Medicamentos , Humanos , Leishmania/genética , Leishmaniasis/enzimología , Leishmaniasis/parasitología , Proteínas Protozoarias/efectos de los fármacos , Proteínas Protozoarias/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA